Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
Darden Restaurants
DRI
$24.4B
| $6.96M | ﹤0.01% |
62,600
-9,000
| -13% | -$1.01M |
|
1502
Brunswick
BC
$5.28B
| $6.96M | ﹤0.01% |
103,827
+57,664
| +125% | +$3.82M |
|
1503
PUT
BP
BP
$107B
| $6.93M | ﹤0.01% |
157,523
-151,017
| -49% | -$6.31M |
|
1504
East-West Bancorp
EWBC
$18B
| $6.93M | ﹤0.01% |
114,764
+9,236
| +9% | +$593K |
|
|
HES
1505
PUT
DELISTED
Hess
HES
| $6.93M | ﹤0.01% |
96,800
-130,100
| -57% | -$8.58M |
|
1506
PUT
Cheniere Energy
LNG
$52.9B
| $6.93M | ﹤0.01% |
99,700
+57,200
| +135% | +$3.69M |
|
1507
PUT
Corning
GLW
$143B
| $6.93M | ﹤0.01% |
196,200
-124,200
| -39% | -$4.03M |
|
|
NLSN
1508
PUT
DELISTED
Nielsen Holdings plc
NLSN
| $6.92M | ﹤0.01% |
250,300
+239,900
| +2,307% | +$6.46M |
|
1509
PUT
Perrigo
PRGO
$1.78B
| $6.92M | ﹤0.01% |
97,700
+87,700
| +877% | +$6.58M |
|
1510
CALL
The Mosaic Company
MOS
$7.33B
| $6.91M | ﹤0.01% |
212,800
+21,500
| +11% | +$648K |
|
1511
CALL
Freeport-McMoran
FCX
$97.5B
| $6.91M | ﹤0.01% |
496,300
-1,750,600
| -78% | -$26.4M |
|
1512
PUT
Alnylam Pharmaceuticals
ALNY
$29.3B
| $6.91M | ﹤0.01% |
78,900
+24,900
| +46% | +$2.5M |
|
1513
CALL
Viatris
VTRS
$18.9B
| $6.9M | ﹤0.01% |
188,600
+58,100
| +45% | +$2.18M |
|
1514
PUT
AnaptysBio
ANAB
$1.68B
| $6.89M | ﹤0.01% |
69,100
+42,300
| +158% | +$3.51M |
|
|
ENDP
1515
CALL
DELISTED
Endo International plc
ENDP
| $6.88M | ﹤0.01% |
408,900
-8,700
| -2% | -$124K |
|
1516
CALL
Eaton
ETN
$174B
| $6.88M | ﹤0.01% |
79,300
+25,800
| +48% | +$2.11M |
|
1517
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $6.87M | ﹤0.01% |
133,200
+39,000
| +41% | +$1.83M |
|
1518
HSBC
HSBC
$356B
| $6.85M | ﹤0.01% |
163,474
+81,881
| +100% | +$3.55M |
|
1519
Assurant
AIZ
$14.3B
| $6.85M | ﹤0.01% |
63,448
-123,488
| -66% | -$13.1M |
|
1520
Lennox International
LII
$15.2B
| $6.85M | ﹤0.01% |
31,364
+20,165
| +180% | +$4.39M |
|
|
THS
1521
DELISTED
Treehouse Foods
THS
| $6.84M | ﹤0.01% |
143,045
+96,212
| +205% | +$4.94M |
|
1522
CALL
Omnicom Group
OMC
$23.4B
| $6.82M | ﹤0.01% |
100,300
-200
| -0.2% | -$14K |
|
1523
Match Group
MTCH
$8.55B
| $6.81M | ﹤0.01% |
117,508
+1,658
| +1% | +$77.7K |
|
1524
Toll Brothers
TOL
$14.5B
| $6.8M | ﹤0.01% |
206,036
+77,894
| +61% | +$2.82M |
|
1525
Wingstop
WING
$3.18B
| $6.79M | ﹤0.01% |
99,487
+34,725
| +54% | +$2.09M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.